Westpac Banking Corp Regeneron Pharmaceuticals, Inc. Transaction History

Westpac Banking Corp

  • $1.49 Trillion
  • Q3 2024

A detailed history of Westpac Banking Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Westpac Banking Corp holds 989 shares of REGN stock, worth $714,127. This represents 0.07% of its overall portfolio holdings.

Number of Shares
989
Previous 923 7.15%
Holding current value
$714,127
Previous $970 Million 7.17%
% of portfolio
0.07%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$1024.09 - $1201.76 $67,589 - $79,316
66 Added 7.15%
989 $1.04 Billion
Q2 2024

Aug 14, 2024
SELL
$883.2 - $1071.19 $113,049 - $137,112
-128 Reduced 12.18%
923 $970 Million
Q2 2024

Aug 12, 2024
BUY
$883.2 - $1071.19 $183,705 - $222,807
208 Added 24.67%
1,051 $970 Million
Q1 2024

May 09, 2024
SELL
$902.69 - $993.35 $16,248 - $17,880
-18 Reduced 2.09%
843 $811 Million
Q4 2023

Feb 08, 2024
BUY
$775.18 - $881.7 $126,354 - $143,717
163 Added 23.35%
861 $756 Million
Q3 2023

Nov 09, 2023
SELL
$692.45 - $844.37 $1.96 Million - $2.39 Million
-2,828 Reduced 80.2%
698 $574 Million
Q2 2023

Aug 10, 2023
SELL
$700.03 - $830.35 $8.57 Million - $10.2 Million
-12,248 Reduced 77.65%
3,526 $2.53 Billion
Q1 2023

May 03, 2023
SELL
$680.49 - $826.97 $2.11 Million - $2.56 Million
-3,096 Reduced 16.41%
15,774 $13 Billion
Q4 2022

Feb 06, 2023
BUY
$705.89 - $766.39 $6.81 Million - $7.39 Million
9,646 Added 104.58%
18,870 $13.6 Billion
Q3 2022

Nov 08, 2022
SELL
$573.97 - $724.32 $232,457 - $293,349
-405 Reduced 4.21%
9,224 $6.35 Billion
Q2 2022

Aug 10, 2022
SELL
$548.35 - $738.84 $3.42 Million - $4.61 Million
-6,233 Reduced 39.3%
9,629 $5.69 Billion
Q1 2022

May 11, 2022
SELL
$595.12 - $698.43 $7.24 Million - $8.49 Million
-12,161 Reduced 43.4%
15,862 $11.1 Million
Q4 2021

Feb 08, 2022
BUY
$543.48 - $670.97 $2.7 Million - $3.33 Million
4,963 Added 21.52%
28,023 $17.7 Billion
Q3 2021

Oct 27, 2021
SELL
$574.03 - $680.96 $5.42 Million - $6.43 Million
-9,447 Reduced 29.06%
23,060 $14 Million
Q2 2021

Aug 11, 2021
BUY
$472.8 - $558.54 $3.6 Million - $4.25 Million
7,613 Added 30.58%
32,507 $18.2 Million
Q1 2021

May 13, 2021
BUY
$446.73 - $548.2 $4.25 Million - $5.21 Million
9,512 Added 61.84%
24,894 $11.8 Million
Q4 2020

Feb 11, 2021
BUY
$478.3 - $607.98 $449,123 - $570,893
939 Added 6.5%
15,382 $7.43 Million
Q3 2020

Nov 10, 2020
SELL
$544.75 - $658.21 $624,828 - $754,966
-1,147 Reduced 7.36%
14,443 $8.08 Million
Q2 2020

Aug 12, 2020
SELL
$493.32 - $643.92 $2.21 Million - $2.88 Million
-4,476 Reduced 22.31%
15,590 $9.72 Million
Q1 2020

May 14, 2020
SELL
$336.18 - $494.43 $762,456 - $1.12 Million
-2,268 Reduced 10.15%
20,066 $9.8 Million
Q4 2019

Feb 11, 2020
BUY
$274.13 - $376.51 $4.08 Million - $5.61 Million
14,896 Added 200.27%
22,334 $8.39 Million
Q3 2019

Nov 13, 2019
SELL
$273.46 - $318.39 $412,924 - $480,768
-1,510 Reduced 16.88%
7,438 $2.06 Million
Q2 2019

Aug 01, 2019
BUY
$299.6 - $414.82 $1.01 Million - $1.4 Million
3,383 Added 60.79%
8,948 $0
Q1 2019

May 14, 2019
BUY
$372.08 - $439.57 $189,388 - $223,741
509 Added 10.07%
5,565 $0
Q2 2018

Jul 18, 2018
SELL
$284.6 - $344.99 $5.09 Million - $6.17 Million
-17,892 Reduced 77.97%
5,056 $0
Q1 2018

May 01, 2018
BUY
$315.82 - $393.78 $1.58 Million - $1.97 Million
4,992 Added 27.8%
22,948 $0
Q4 2017

Jan 18, 2018
BUY
$358.63 - $469.95 $358,630 - $469,950
1,000 Added 5.9%
17,956 $0
Q3 2017

Oct 30, 2017
BUY
$431.38 - $504.0 $7.31 Million - $8.55 Million
16,956
16,956 $0

Others Institutions Holding REGN

# of Institutions
1,494
Shares Held
83.1M
Call Options Held
1.22M
Put Options Held
1.5M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $77.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Westpac Banking Corp Portfolio

Follow Westpac Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email